SBIR/STTR Recipient

Magnetic Tides

Brief Description

Magnetic Tides has developed a new non-invasive brain stimulation (NIBS) system capable of modulating brain function more reliably and effectively than previously existing NIBS methods.

NIBS is used as a research tool to safely, transiently alter the excitability state of targeted neurons when testing causal hypotheses about brain-behavior relationships. In addition, clinicians have recognized the potential of NIBS as a new intervention in the treatment of neurological and psychiatric disorders.

Inventors

Richard Ivry, Ludovica Labruna, Benjamin Inglis,...

CalWave

Brief Description

CalWave Power Technologies Inc. provides a solution to harness the renewable power of ocean waves to produce electricity and freshwater. CalWave’s patented Wave Energy Converter (WEC) is moored offshore, simple and scalable. WEC operates submerged, allowing it to survive stormy seas while causing no visual pollution or posing any collision danger.

CalWave co-founder and CEO Marcus Lehmann co-invented the company's foundational technology during his time as a visiting scholar at the UC Berkeley Theoretical & Applied Fluid Dynamics Laboratory. Marcus was inspired...

Sonera Magnetics

Brief Description

Magnetometers are nearly ubiquitous in today’s world, fueling applications as diverse as medical diagnostics and self-driving cars. The most sensitive magnetometers, however, can only operate at extreme temperatures and in a shielded environment that isolates the sensor from ambient magnetic fields. Sonera Magnetics is developing a magnetometer that can operate at room temperature and in portable form factors with sensitivity comparable to the best magnetic sensors available today, dramatically increasing potential applications.

Co-founders Dominic Labanowski and...

EditPep, Inc.

Brief Description

CRISPR therapies enabled by a simple, potent delivery platform. The biotechnology company creates a class of peptides capable of delivering CRISPR enzymes into clinically-relevant and previously untransfectable cell types, enabling clients to get CRISPR therapies.

Inventors

Ross Wilson, Dana Foss, Alexander Marson, Srishti Sahu, David-Huy Nguyen, John Hunsinger, Daniel Carr

Company Founders

Dana Foss (UC Berkeley postdoc 2017-2022), UC Berkeley Assistant Adjunct Professor of Molecular Therapeutics Ross Wilson

Timeline 2021...

Xip Diagnostics

Brief Description

Xip Diagnostics develops analytical solutions that advance human and animal health at the point of need through in-house product development and industry-leading collaborations.

The company's disposable blood analyzers wirelessly upload lab-quality clinical measurements in minutes, providing blood testing with no hassles, no delays, and no instrument. These devices will be deployed in Emergency Departments (EDs), clinics, and eventually the home.

Xip Diagnostics Founder and CEO Dr. Octavian Florescu spun out the company to commercialize research discoveries...

Photoswitch Biosciences Inc.

Brief Description

Photoswitch Biosciences was founded in 2010 to advance applications of designed-for-purpose, photo-activated ion channels. It became clear that new tools were needed to advance the research. The therapeutic mission has been separated so that Photoswitch Biosciences today can focus on providing advanced tools to the research community.

Our mission is to provide best-in-class instrumentation to the industrial and academic research communities. Founded by scientists familiar with need for reliable instrumentation and advanced software, the user experience is at the...

mFluiDx

Brief Description

mFluiDx is aiming to develop the world’s lowest cost, automated point-of-care DNA diagnostic assay for small clinics. In small clinics, such as primary care out-patient clinics, disease diagnosis is typically done by observing symptoms or using paper-strip antibody tests. However, these methods have poor sensitivity compared to DNA diagnostics. Highly sensitive molecular DNA tests (PCR) are not often used because of cost and the need to send tests off-site resulting in a slow turnaround time (several days).

mFluiDx is a UC Berkeley startup developing Gates...

ReRx Therapeutics

Brief Description

ReRx is developing novel oral small molecule therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. The company's therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents.

Obesity and its associated metabolic diseases remain leading causes of preventable illness and mortality worldwide. Current front-line treatments, notably injectable incretin analogs that suppress appetite and reduce food...

Resvita Biosciences

Brief Description

Resvita Biosciences seeks to restore and maintain the vitality of the skin by properly considering the skin microbiome as part of the human body. A harmless skin probiotic will continuously deliver the therapy that a body would to maintain skin health.

Through synthetic biology and metabolic engineering, the company's goal is to develop a safe and versatile skin microbial platform that can address the causes of skin aging and disease. Resvita Biosciences has a unique patented approach, a rich product pipeline, clear regulatory advantages, and an experienced...

Calyx

Brief Description

Calyx is a materials science company that harnesses biology to provide low cost and highly accurate sensors for real-time detection and analysis of air chemicals in a variety of industries, including safety, healthcare, transportation, and food. The company offers commercial customers phage-based sensing and analysis of multiple gasses.

Company co-founders Ray Chiu and Benson Fan developed the company’s founding technology as a capstone project while they were students in the UC Berkeley-UCSF Masters in Bioengineering program. With the encouragement of UC Berkeley...